Report Detail
COVID-19 Impact on Global Cell Therapy and Tissue Engineering Market Size, Status and Forecast 2020-2026
- RnM4017475 |
- 09 June, 2020 |
- Global |
- 152 Pages |
- QYResearch |
- Medical Devices & Consumables
This report focuses on the global Cell Therapy and Tissue Engineering status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cell Therapy and Tissue Engineering development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Betalin Therapeutics
BioCardia, Inc
BioReliance Corporation
Biosolution Co.
Brainstorm Cell Therapeutics, Inc
MaxCyte, Inc
Medigene AG
MEDIPOST CO.
Mesoblast Limited
Miromatrix Medical, Inc.
MolMed S.p.A
Mustang Bio, Inc
NantKwest, Inc.
Neuralstem, Inc
NexImmune, Inc.
Nohla Therapeutics, Inc
ReNeuron Group plc
Richter-Helm BioLogics GmbH & Co. KG
RoosterBio, Inc
RoslinCT
Rubius Therapeutics, Inc.
Sangamo Therapeutics, Inc
Voyager Therapeutics, Inc
Waisman Biomanufacturing
WindMIL Therapeutics, Inc.
Wuxi App Tec, Inc.
ReNeuron Group plc
Richter-Helm BioLogics GmbH & Co. KG
RoosterBio, Inc
RoslinCT
Market segment by Type, the product can be split into
Cell Therapy
Tissue Engineering
Market segment by Application, split into
Cell Defects
Genetic Diseases
Neurodegenerative Diseases
Tissue Malignancies
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Cell Therapy and Tissue Engineering status, future forecast, growth opportunity, key market and key players.
To present the Cell Therapy and Tissue Engineering development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Cell Therapy and Tissue Engineering are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered: Ranking by Cell Therapy and Tissue Engineering Revenue
- 1.4 Market Analysis by Type
- 1.4.1 Global Cell Therapy and Tissue Engineering Market Size Growth Rate by Type: 2020 VS 2026
- 1.4.2 Cell Therapy
- 1.4.3 Tissue Engineering
- 1.5 Market by Application
- 1.5.1 Global Cell Therapy and Tissue Engineering Market Share by Application: 2020 VS 2026
- 1.5.2 Cell Defects
- 1.5.3 Genetic Diseases
- 1.5.4 Neurodegenerative Diseases
- 1.5.5 Tissue Malignancies
- 1.5.6 Others
- 1.6 Coronavirus Disease 2019 (Covid-19): Cell Therapy and Tissue Engineering Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Cell Therapy and Tissue Engineering Industry
- 1.6.1.1 Cell Therapy and Tissue Engineering Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Cell Therapy and Tissue Engineering Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Cell Therapy and Tissue Engineering Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Cell Therapy and Tissue Engineering Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Global Growth Trends by Regions
- 2.1 Cell Therapy and Tissue Engineering Market Perspective (2015-2026)
- 2.2 Cell Therapy and Tissue Engineering Growth Trends by Regions
- 2.2.1 Cell Therapy and Tissue Engineering Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 Cell Therapy and Tissue Engineering Historic Market Share by Regions (2015-2020)
- 2.2.3 Cell Therapy and Tissue Engineering Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
- 2.3.5 Cell Therapy and Tissue Engineering Market Growth Strategy
- 2.3.6 Primary Interviews with Key Cell Therapy and Tissue Engineering Players (Opinion Leaders)
3 Competition Landscape by Key Players
- 3.1 Global Top Cell Therapy and Tissue Engineering Players by Market Size
- 3.1.1 Global Top Cell Therapy and Tissue Engineering Players by Revenue (2015-2020)
- 3.1.2 Global Cell Therapy and Tissue Engineering Revenue Market Share by Players (2015-2020)
- 3.1.3 Global Cell Therapy and Tissue Engineering Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.2 Global Cell Therapy and Tissue Engineering Market Concentration Ratio
- 3.2.1 Global Cell Therapy and Tissue Engineering Market Concentration Ratio (CR5 and HHI)
- 3.2.2 Global Top 10 and Top 5 Companies by Cell Therapy and Tissue Engineering Revenue in 2019
- 3.3 Cell Therapy and Tissue Engineering Key Players Head office and Area Served
- 3.4 Key Players Cell Therapy and Tissue Engineering Product Solution and Service
- 3.5 Date of Enter into Cell Therapy and Tissue Engineering Market
- 3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Cell Therapy and Tissue Engineering Historic Market Size by Type (2015-2020)
- 4.2 Global Cell Therapy and Tissue Engineering Forecasted Market Size by Type (2021-2026)
5 Cell Therapy and Tissue Engineering Breakdown Data by Application (2015-2026)
- 5.1 Global Cell Therapy and Tissue Engineering Market Size by Application (2015-2020)
- 5.2 Global Cell Therapy and Tissue Engineering Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America Cell Therapy and Tissue Engineering Market Size (2015-2020)
- 6.2 Cell Therapy and Tissue Engineering Key Players in North America (2019-2020)
- 6.3 North America Cell Therapy and Tissue Engineering Market Size by Type (2015-2020)
- 6.4 North America Cell Therapy and Tissue Engineering Market Size by Application (2015-2020)
7 Europe
- 7.1 Europe Cell Therapy and Tissue Engineering Market Size (2015-2020)
- 7.2 Cell Therapy and Tissue Engineering Key Players in Europe (2019-2020)
- 7.3 Europe Cell Therapy and Tissue Engineering Market Size by Type (2015-2020)
- 7.4 Europe Cell Therapy and Tissue Engineering Market Size by Application (2015-2020)
8 China
- 8.1 China Cell Therapy and Tissue Engineering Market Size (2015-2020)
- 8.2 Cell Therapy and Tissue Engineering Key Players in China (2019-2020)
- 8.3 China Cell Therapy and Tissue Engineering Market Size by Type (2015-2020)
- 8.4 China Cell Therapy and Tissue Engineering Market Size by Application (2015-2020)
9 Japan
- 9.1 Japan Cell Therapy and Tissue Engineering Market Size (2015-2020)
- 9.2 Cell Therapy and Tissue Engineering Key Players in Japan (2019-2020)
- 9.3 Japan Cell Therapy and Tissue Engineering Market Size by Type (2015-2020)
- 9.4 Japan Cell Therapy and Tissue Engineering Market Size by Application (2015-2020)
10 Southeast Asia
- 10.1 Southeast Asia Cell Therapy and Tissue Engineering Market Size (2015-2020)
- 10.2 Cell Therapy and Tissue Engineering Key Players in Southeast Asia (2019-2020)
- 10.3 Southeast Asia Cell Therapy and Tissue Engineering Market Size by Type (2015-2020)
- 10.4 Southeast Asia Cell Therapy and Tissue Engineering Market Size by Application (2015-2020)
11 India
- 11.1 India Cell Therapy and Tissue Engineering Market Size (2015-2020)
- 11.2 Cell Therapy and Tissue Engineering Key Players in India (2019-2020)
- 11.3 India Cell Therapy and Tissue Engineering Market Size by Type (2015-2020)
- 11.4 India Cell Therapy and Tissue Engineering Market Size by Application (2015-2020)
12 Central & South America
- 12.1 Central & South America Cell Therapy and Tissue Engineering Market Size (2015-2020)
- 12.2 Cell Therapy and Tissue Engineering Key Players in Central & South America (2019-2020)
- 12.3 Central & South America Cell Therapy and Tissue Engineering Market Size by Type (2015-2020)
- 12.4 Central & South America Cell Therapy and Tissue Engineering Market Size by Application (2015-2020)
13 Key Players Profiles
- 13.1 Betalin Therapeutics
- 13.1.1 Betalin Therapeutics Company Details
- 13.1.2 Betalin Therapeutics Business Overview and Its Total Revenue
- 13.1.3 Betalin Therapeutics Cell Therapy and Tissue Engineering Introduction
- 13.1.4 Betalin Therapeutics Revenue in Cell Therapy and Tissue Engineering Business (2015-2020))
- 13.1.5 Betalin Therapeutics Recent Development
- 13.2 BioCardia, Inc
- 13.2.1 BioCardia, Inc Company Details
- 13.2.2 BioCardia, Inc Business Overview and Its Total Revenue
- 13.2.3 BioCardia, Inc Cell Therapy and Tissue Engineering Introduction
- 13.2.4 BioCardia, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
- 13.2.5 BioCardia, Inc Recent Development
- 13.3 BioReliance Corporation
- 13.3.1 BioReliance Corporation Company Details
- 13.3.2 BioReliance Corporation Business Overview and Its Total Revenue
- 13.3.3 BioReliance Corporation Cell Therapy and Tissue Engineering Introduction
- 13.3.4 BioReliance Corporation Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
- 13.3.5 BioReliance Corporation Recent Development
- 13.4 Biosolution Co.
- 13.4.1 Biosolution Co. Company Details
- 13.4.2 Biosolution Co. Business Overview and Its Total Revenue
- 13.4.3 Biosolution Co. Cell Therapy and Tissue Engineering Introduction
- 13.4.4 Biosolution Co. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
- 13.4.5 Biosolution Co. Recent Development
- 13.5 Brainstorm Cell Therapeutics, Inc
- 13.5.1 Brainstorm Cell Therapeutics, Inc Company Details
- 13.5.2 Brainstorm Cell Therapeutics, Inc Business Overview and Its Total Revenue
- 13.5.3 Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Introduction
- 13.5.4 Brainstorm Cell Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
- 13.5.5 Brainstorm Cell Therapeutics, Inc Recent Development
- 13.6 MaxCyte, Inc
- 13.6.1 MaxCyte, Inc Company Details
- 13.6.2 MaxCyte, Inc Business Overview and Its Total Revenue
- 13.6.3 MaxCyte, Inc Cell Therapy and Tissue Engineering Introduction
- 13.6.4 MaxCyte, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
- 13.6.5 MaxCyte, Inc Recent Development
- 13.7 Medigene AG
- 13.7.1 Medigene AG Company Details
- 13.7.2 Medigene AG Business Overview and Its Total Revenue
- 13.7.3 Medigene AG Cell Therapy and Tissue Engineering Introduction
- 13.7.4 Medigene AG Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
- 13.7.5 Medigene AG Recent Development
- 13.8 MEDIPOST CO.
- 13.8.1 MEDIPOST CO. Company Details
- 13.8.2 MEDIPOST CO. Business Overview and Its Total Revenue
- 13.8.3 MEDIPOST CO. Cell Therapy and Tissue Engineering Introduction
- 13.8.4 MEDIPOST CO. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
- 13.8.5 MEDIPOST CO. Recent Development
- 13.9 Mesoblast Limited
- 13.9.1 Mesoblast Limited Company Details
- 13.9.2 Mesoblast Limited Business Overview and Its Total Revenue
- 13.9.3 Mesoblast Limited Cell Therapy and Tissue Engineering Introduction
- 13.9.4 Mesoblast Limited Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
- 13.9.5 Mesoblast Limited Recent Development
- 13.10 Miromatrix Medical, Inc.
- 13.10.1 Miromatrix Medical, Inc. Company Details
- 13.10.2 Miromatrix Medical, Inc. Business Overview and Its Total Revenue
- 13.10.3 Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Introduction
- 13.10.4 Miromatrix Medical, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
- 13.10.5 Miromatrix Medical, Inc. Recent Development
- 13.11 MolMed S.p.A
- 10.11.1 MolMed S.p.A Company Details
- 10.11.2 MolMed S.p.A Business Overview and Its Total Revenue
- 10.11.3 MolMed S.p.A Cell Therapy and Tissue Engineering Introduction
- 10.11.4 MolMed S.p.A Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
- 10.11.5 MolMed S.p.A Recent Development
- 13.12 Mustang Bio, Inc
- 10.12.1 Mustang Bio, Inc Company Details
- 10.12.2 Mustang Bio, Inc Business Overview and Its Total Revenue
- 10.12.3 Mustang Bio, Inc Cell Therapy and Tissue Engineering Introduction
- 10.12.4 Mustang Bio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
- 10.12.5 Mustang Bio, Inc Recent Development
- 13.13 NantKwest, Inc.
- 10.13.1 NantKwest, Inc. Company Details
- 10.13.2 NantKwest, Inc. Business Overview and Its Total Revenue
- 10.13.3 NantKwest, Inc. Cell Therapy and Tissue Engineering Introduction
- 10.13.4 NantKwest, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
- 10.13.5 NantKwest, Inc. Recent Development
- 13.14 Neuralstem, Inc
- 10.14.1 Neuralstem, Inc Company Details
- 10.14.2 Neuralstem, Inc Business Overview and Its Total Revenue
- 10.14.3 Neuralstem, Inc Cell Therapy and Tissue Engineering Introduction
- 10.14.4 Neuralstem, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
- 10.14.5 Neuralstem, Inc Recent Development
- 13.15 NexImmune, Inc.
- 10.15.1 NexImmune, Inc. Company Details
- 10.15.2 NexImmune, Inc. Business Overview and Its Total Revenue
- 10.15.3 NexImmune, Inc. Cell Therapy and Tissue Engineering Introduction
- 10.15.4 NexImmune, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
- 10.15.5 NexImmune, Inc. Recent Development
- 13.16 Nohla Therapeutics, Inc
- 10.16.1 Nohla Therapeutics, Inc Company Details
- 10.16.2 Nohla Therapeutics, Inc Business Overview and Its Total Revenue
- 10.16.3 Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Introduction
- 10.16.4 Nohla Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
- 10.16.5 Nohla Therapeutics, Inc Recent Development
- 13.17 ReNeuron Group plc
- 10.17.1 ReNeuron Group plc Company Details
- 10.17.2 ReNeuron Group plc Business Overview and Its Total Revenue
- 10.17.3 ReNeuron Group plc Cell Therapy and Tissue Engineering Introduction
- 10.17.4 ReNeuron Group plc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
- 10.17.5 ReNeuron Group plc Recent Development
- 13.18 Richter-Helm BioLogics GmbH & Co. KG
- 10.18.1 Richter-Helm BioLogics GmbH & Co. KG Company Details
- 10.18.2 Richter-Helm BioLogics GmbH & Co. KG Business Overview and Its Total Revenue
- 10.18.3 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Introduction
- 10.18.4 Richter-Helm BioLogics GmbH & Co. KG Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
- 10.18.5 Richter-Helm BioLogics GmbH & Co. KG Recent Development
- 13.19 RoosterBio, Inc
- 10.19.1 RoosterBio, Inc Company Details
- 10.19.2 RoosterBio, Inc Business Overview and Its Total Revenue
- 10.19.3 RoosterBio, Inc Cell Therapy and Tissue Engineering Introduction
- 10.19.4 RoosterBio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
- 10.19.5 RoosterBio, Inc Recent Development
- 13.20 RoslinCT
- 10.20.1 RoslinCT Company Details
- 10.20.2 RoslinCT Business Overview and Its Total Revenue
- 10.20.3 RoslinCT Cell Therapy and Tissue Engineering Introduction
- 10.20.4 RoslinCT Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
- 10.20.5 RoslinCT Recent Development
- 13.21 Rubius Therapeutics, Inc.
- 10.21.1 Rubius Therapeutics, Inc. Company Details
- 10.21.2 Rubius Therapeutics, Inc. Business Overview and Its Total Revenue
- 10.21.3 Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Introduction
- 10.21.4 Rubius Therapeutics, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
- 10.21.5 Rubius Therapeutics, Inc. Recent Development
- 13.22 Sangamo Therapeutics, Inc
- 10.22.1 Sangamo Therapeutics, Inc Company Details
- 10.22.2 Sangamo Therapeutics, Inc Business Overview and Its Total Revenue
- 10.22.3 Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Introduction
- 10.22.4 Sangamo Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
- 10.22.5 Sangamo Therapeutics, Inc Recent Development
- 13.23 Voyager Therapeutics, Inc
- 10.23.1 Voyager Therapeutics, Inc Company Details
- 10.23.2 Voyager Therapeutics, Inc Business Overview and Its Total Revenue
- 10.23.3 Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Introduction
- 10.23.4 Voyager Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
- 10.23.5 Voyager Therapeutics, Inc Recent Development
- 13.24 Waisman Biomanufacturing
- 10.24.1 Waisman Biomanufacturing Company Details
- 10.24.2 Waisman Biomanufacturing Business Overview and Its Total Revenue
- 10.24.3 Waisman Biomanufacturing Cell Therapy and Tissue Engineering Introduction
- 10.24.4 Waisman Biomanufacturing Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
- 10.24.5 Waisman Biomanufacturing Recent Development
- 13.25 WindMIL Therapeutics, Inc.
- 10.25.1 WindMIL Therapeutics, Inc. Company Details
- 10.25.2 WindMIL Therapeutics, Inc. Business Overview and Its Total Revenue
- 10.25.3 WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Introduction
- 10.25.4 WindMIL Therapeutics, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
- 10.25.5 WindMIL Therapeutics, Inc. Recent Development
- 13.26 Wuxi App Tec, Inc.
- 10.26.1 Wuxi App Tec, Inc. Company Details
- 10.26.2 Wuxi App Tec, Inc. Business Overview and Its Total Revenue
- 10.26.3 Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Introduction
- 10.26.4 Wuxi App Tec, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
- 10.26.5 Wuxi App Tec, Inc. Recent Development
- 13.27 ReNeuron Group plc
- 10.27.1 ReNeuron Group plc Company Details
- 10.27.2 ReNeuron Group plc Business Overview and Its Total Revenue
- 10.27.3 ReNeuron Group plc Cell Therapy and Tissue Engineering Introduction
- 10.27.4 ReNeuron Group plc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
- 10.27.5 ReNeuron Group plc Recent Development
- 13.28 Richter-Helm BioLogics GmbH & Co. KG
- 10.28.1 Richter-Helm BioLogics GmbH & Co. KG Company Details
- 10.28.2 Richter-Helm BioLogics GmbH & Co. KG Business Overview and Its Total Revenue
- 10.28.3 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Introduction
- 10.28.4 Richter-Helm BioLogics GmbH & Co. KG Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
- 10.28.5 Richter-Helm BioLogics GmbH & Co. KG Recent Development
- 13.29 RoosterBio, Inc
- 10.29.1 RoosterBio, Inc Company Details
- 10.29.2 RoosterBio, Inc Business Overview and Its Total Revenue
- 10.29.3 RoosterBio, Inc Cell Therapy and Tissue Engineering Introduction
- 10.29.4 RoosterBio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
- 10.29.5 RoosterBio, Inc Recent Development
- 13.30 RoslinCT
- 10.30.1 RoslinCT Company Details
- 10.30.2 RoslinCT Business Overview and Its Total Revenue
- 10.30.3 RoslinCT Cell Therapy and Tissue Engineering Introduction
- 10.30.4 RoslinCT Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
- 10.30.5 RoslinCT Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Cell Therapy and Tissue Engineering. Industry analysis & Market Report on COVID-19 Impact on Global Cell Therapy and Tissue Engineering is a syndicated market report, published as COVID-19 Impact on Global Cell Therapy and Tissue Engineering Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Cell Therapy and Tissue Engineering market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
